Author

Naomi Bryant

University of VirginiaORCID 0000-0001-5807-9397Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:machine learning (classical)· 2 Research Focus:cell-cell communication· 1 Research Focus:trajectory inference· 1

Frequent Co-Authors

Judith A. WoodfolkiD· 2 shared Lyndsey M. MuehlingiD· 2 shared Alexandra KadliD· 1 shared Behnam KeshavarziD· 1 shared Catherine A. BonhamiD· 1 shared Chintan Ramani· 1 shared Claire E. CrossiD· 1 shared Coleen A. McNamaraiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Judith A. WoodfolkORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Rhinovirus as a Driver of Airway T-Cell Dynamics in Children with Severe Asthma

Naomi Bryant, Lyndsey M. Muehling, Kristin Wavell, William Gerald Teague, Judith A. Woodfolk

The paper uses machine learning to analyze T-cell dynamics in children with severe asthma, identifying rhinovirus-driven changes in T-cell signatures and differentiation pathways.

JCI Insight · May 7, 2025Peer-reviewedImmunology

Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19

Glenda Canderan, Lyndsey M. Muehling, Alexandra Kadl, Shay Ladd, Catherine A. Bonham, Claire E. Cross, Sierra M. Lima, Xihui Yin, Jeffrey M. Sturek, Jeffrey M. Wilson, Behnam Keshavarz, Kyle B. Enfield, Chintan Ramani, Naomi Bryant, Deborah D. Murphy, , Judith A. Woodfolk

The paper identifies distinct type 1 immune networks associated with varying severities of restrictive lung disease following COVID-19.

Nature Immunology · Mar 26, 2025Peer-reviewedImmunology